Brief: CEL-SCI Corporation announces Phase 3 Multikine® head and neck cancer results posted on clinicaltrials.gov
19/08/2022 13:48
Aug 19 (Reuters) - CEL-SCI Corp CVM.A :
* CEL-SCI CORPORATION ANNOUNCES PHASE 3 MULTIKINE® HEAD AND
NECK
CANCER RESULTS POSTED ON CLINICALTRIALS.GOV
* CEL-SCI CORP - PHASE 3 MULTIKINE TRIAL IS INTENDED TO
SUPPORT A
BLA TO FDA, WHICH HAS NOT YET BEEN SUBMITTED
Source text for Eikon: ID:nBwbyxNrCa
Further company coverage: CVM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CEL-SCI
See all newsBrief: CEL-SCI Announces Closing Of Offering
Brief: Cel-Sci Corp Files For Offering Of 6 Million Shares Of Common Stock- SEC Filing
Brief: Cel-Sci Corporation Announces Pricing Of Public Offering
Brief: CEL-SCI Enters Strategic Agreement With Amarox For The Registration, Commercialization, And Distribution Of Multikine In Saudi Arabia
Drug developer CEL-SCI dives on deep-discounted equity raise